Cargando…
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
Plasma-derived polyclonal antibody therapeutics, such as intravenous immunoglobulin, have multiple drawbacks, including low potency, impurities, insufficient supply, and batch-to-batch variation. Here we describe a microfluidics and molecular genomics strategy for capturing diverse mammalian antibod...
Ejemplares similares
-
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022) -
Preferential Identification of Agonistic OX40 Antibodies by Using Cell Lysate to Pan Natively Paired, Humanized Mouse-Derived Yeast Surface Display Libraries
por: Medina-Cucurella, Angélica V., et al.
Publicado: (2019) -
Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics
por: Asensio, Michael A., et al.
Publicado: (2019) -
Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics
por: Adler, Adam S., et al.
Publicado: (2017) -
A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Wayham, Nicholas P, et al.
Publicado: (2023)